MetaADEDB 2.0 @ LMMD
Olanzapine pamoate
(ZIMCQJVMPKQQPB-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O.CN1CCN(CC1)C1=Nc2ccccc2Nc2c1cc(s2)C.O
Molecular Formula:
C40H38N4O7S
Molecular Weight:
718.817
Log P:
7.2157
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
6
TPSA:
183.4
CAS Number(s):
221373-18-8
Synonym(s)
1.
Olanzapine pamoate
External Link(s)
PubChem Compound135566032
CHEMBLCHEMBL3989694
KEGGdr:D06623
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DysarthriaFAERS: 43US FAERS
2SomnolenceFAERS: 42US FAERS
3AgitationFAERS: 31US FAERS
4Drug dose omissionFAERS: 27US FAERS
5DizzinessFAERS: 24US FAERS
6Post-injection delirium sedation syndromeFAERS: 22US FAERS
7Drug ineffectiveFAERS: 20US FAERS
8DisorientationFAERS: 16US FAERS
9FatigueFAERS: 16US FAERS
10AnxietyFAERS: 15US FAERS
11DeliriumFAERS: 13US FAERS
12Prescribed overdoseFAERS: 13US FAERS
13Psychiatric decompensationFAERS: 13US FAERS
14AtaxiaFAERS: 12US FAERS
15RestlessnessFAERS: 12US FAERS
16SchizophreniaFAERS: 11US FAERS
17Feeling abnormalFAERS: 10US FAERS
18OverdoseFAERS: 10US FAERS
19AstheniaFAERS: 9US FAERS
20Inappropriate schedule of drug administrationFAERS: 9US FAERS
21MalaiseFAERS: 9US FAERS
22Unresponsive to stimuliFAERS: 9US FAERS
23Weight decreasedFAERS: 8US FAERS
24InfluenzaFAERS: 7US FAERS
25PallorFAERS: 7US FAERS
26Accidental exposure to productFAERS: 6US FAERS
27Blood glucose increasedFAERS: 6US FAERS
28HypotensionFAERS: 6US FAERS
29TachycardiaFAERS: 6US FAERS
30HypersomniaFAERS: 5US FAERS
31Injection site painFAERS: 5US FAERS
32PainFAERS: 5US FAERS
33PneumoniaFAERS: 5US FAERS
34Drug abuseFAERS: 4US FAERS
35Injection site abscessFAERS: 4US FAERS
36Injection site infectionFAERS: 4US FAERS
37Neutrophil count decreasedFAERS: 4US FAERS
38ParanoiaFAERS: 4US FAERS
39TremorFAERS: 4US FAERS
40Urinary tract infectionFAERS: 4US FAERS
41Adverse eventFAERS: 3US FAERS
42AkathisiaFAERS: 3US FAERS
43Completed SuicideFAERS: 3US FAERS
44DehydrationFAERS: 3US FAERS
45DroolingFAERS: 3US FAERS
46Drug effect incompleteFAERS: 3US FAERS
47Feeling of body temperature changeFAERS: 3US FAERS
48Injection site erythemaFAERS: 3US FAERS
49Memory impairmentFAERS: 3US FAERS
50Mental impairmentFAERS: 3US FAERS
51Myocardial InfarctionFAERS: 3US FAERS
52SyncopeFAERS: 3US FAERS
53Toxicity to various agentsFAERS: 3US FAERS
54Urinary IncontinenceFAERS: 3US FAERS
55VomitingFAERS: 3US FAERS
56AlopeciaFAERS: 2US FAERS
57AphasiaFAERS: 2US FAERS
58ArthralgiaFAERS: 2US FAERS
59Atrial FibrillationFAERS: 2US FAERS
60Blood creatine phosphokinase increasedFAERS: 2US FAERS
61Cerebrovascular accidentFAERS: 2US FAERS
62ChillsFAERS: 2US FAERS
63CholelithiasisFAERS: 2US FAERS
64Coma scale abnormalFAERS: 2US FAERS
65CyanosisFAERS: 2US FAERS
66Depressed moodFAERS: 2US FAERS
67Diabetes MellitusFAERS: 2US FAERS
68Drug administered at inappropriate siteFAERS: 2US FAERS
69ErythemaFAERS: 2US FAERS
70Escherichia sepsisFAERS: 2US FAERS
71Facial paralysisFAERS: 2US FAERS
72Feeling ColdFAERS: 2US FAERS
73HeadacheFAERS: 2US FAERS
74Injection site cystFAERS: 2US FAERS
75Injection site discomfortFAERS: 2US FAERS
76Injection site extravasationFAERS: 2US FAERS
77Injection site pruritusFAERS: 2US FAERS
78LethargyFAERS: 2US FAERS
79Limb discomfortFAERS: 2US FAERS
80Limb injuryFAERS: 2US FAERS
81Medication ErrorFAERS: 2US FAERS
82Musculoskeletal stiffnessFAERS: 2US FAERS
83MyalgiaFAERS: 2US FAERS
84NasopharyngitisFAERS: 2US FAERS
85NauseaFAERS: 2US FAERS
86No adverse eventFAERS: 2US FAERS
87Orthostatic intoleranceFAERS: 2US FAERS
88PalpitationsFAERS: 2US FAERS
89Poor quality sleepFAERS: 2US FAERS
90Post procedural complicationFAERS: 2US FAERS
91PresyncopeFAERS: 2US FAERS
92Restless Legs SyndromeFAERS: 2US FAERS
93StressFAERS: 2US FAERS
94White blood cell count decreasedFAERS: 2US FAERS
95AbasiaFAERS: 1US FAERS
96Abdominal PainFAERS: 1US FAERS
97Abdominal discomfortFAERS: 1US FAERS
98AbscessFAERS: 1US FAERS
99Alanine Aminotransferase IncreasedFAERS: 1US FAERS
100Alcohol abuseFAERS: 1US FAERS
101Alcohol poisoningFAERS: 1US FAERS
102AmnesiaFAERS: 1US FAERS
103AngerFAERS: 1US FAERS
104Angina PectorisFAERS: 1US FAERS
105Animal biteFAERS: 1US FAERS
106Aortic AneurysmFAERS: 1US FAERS
107ApathyFAERS: 1US FAERS
108AppendicitisFAERS: 1US FAERS
109Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
110Back PainFAERS: 1US FAERS
111Blood glucose decreasedFAERS: 1US FAERS
112Blood potassium decreasedFAERS: 1US FAERS
113Blood triglycerides increasedFAERS: 1US FAERS
114Blood triglyceridesFAERS: 1US FAERS
115BoredomFAERS: 1US FAERS
116BradykinesiaFAERS: 1US FAERS
117BradyphreniaFAERS: 1US FAERS
118BronchopneumoniaFAERS: 1US FAERS
119Cardiac DeathFAERS: 1US FAERS
120Cardiac infectionFAERS: 1US FAERS
121CardiomegalyFAERS: 1US FAERS
122CellulitisFAERS: 1US FAERS
123Chest PainFAERS: 1US FAERS
124ChokingFAERS: 1US FAERS
125Cold sweatFAERS: 1US FAERS
126Consciousness fluctuatingFAERS: 1US FAERS
127ConstipationFAERS: 1US FAERS
128Delusional disorder, unspecified typeFAERS: 1US FAERS
129Depressed Level of ConsciousnessFAERS: 1US FAERS
130Depression suicidalFAERS: 1US FAERS
131Diet refusalFAERS: 1US FAERS
132DiplopiaFAERS: 1US FAERS
133DiscomfortFAERS: 1US FAERS
134DrowningFAERS: 1US FAERS
135Drug administration errorFAERS: 1US FAERS
136Drug level above therapeuticFAERS: 1US FAERS
137DysgeusiaFAERS: 1US FAERS
138DysphoniaFAERS: 1US FAERS
139EpistaxisFAERS: 1US FAERS
140Expired product administeredFAERS: 1US FAERS
141FlushingFAERS: 1US FAERS
142General physical health deteriorationFAERS: 1US FAERS
143Hepatitis CFAERS: 1US FAERS
144HyperreflexiaFAERS: 1US FAERS
145HypersensitivityFAERS: 1US FAERS
146HypokinesiaFAERS: 1US FAERS
147HypophagiaFAERS: 1US FAERS
148Inappropriate affectFAERS: 1US FAERS
149Inappropriate schedule of product administrationFAERS: 1US FAERS
150IncoherentFAERS: 1US FAERS
151Incorrect dose administeredFAERS: 1US FAERS
152InfarctionFAERS: 1US FAERS
153Injection Site ReactionFAERS: 1US FAERS
154Injection site bruisingFAERS: 1US FAERS
155Injection site inflammationFAERS: 1US FAERS
156Injection site irritationFAERS: 1US FAERS
157Injection site massFAERS: 1US FAERS
158Injection site urticariaFAERS: 1US FAERS
159Injection site vesiclesFAERS: 1US FAERS
160Injection site warmthFAERS: 1US FAERS
161Intentional product misuseFAERS: 1US FAERS
162Intentional self-injuryFAERS: 1US FAERS
163Intercepted product selection errorFAERS: 1US FAERS
164Intestinal ObstructionFAERS: 1US FAERS
165Intestinal PerforationFAERS: 1US FAERS
166Joint injuryFAERS: 1US FAERS
167Joint stiffnessFAERS: 1US FAERS
168Lower respiratory tract infectionFAERS: 1US FAERS
169Mental status changesFAERS: 1US FAERS
170MyoclonusFAERS: 1US FAERS
171Needle issueFAERS: 1US FAERS
172NervousnessFAERS: 1US FAERS
173Neuroleptic Malignant SyndromeFAERS: 1US FAERS
174Neurological infectionFAERS: 1US FAERS
175ObesityFAERS: 1US FAERS
176Obsessive-Compulsive DisorderFAERS: 1US FAERS
177Oromandibular dystoniaFAERS: 1US FAERS
178ParaparesisFAERS: 1US FAERS
179Peripheral swellingFAERS: 1US FAERS
180Physical assaultFAERS: 1US FAERS
181Poor personal hygieneFAERS: 1US FAERS
182PriapismFAERS: 1US FAERS
183Procedural complicationFAERS: 1US FAERS
184Product preparation errorFAERS: 1US FAERS
185PruritusFAERS: 1US FAERS
186PsoriasisFAERS: 1US FAERS
187Psychiatric symptomFAERS: 1US FAERS
188Respiratory DepressionFAERS: 1US FAERS
189Respiratory arrestFAERS: 1US FAERS
190Respiratory distressFAERS: 1US FAERS
191Schizoaffective DisorderFAERS: 1US FAERS
192ScreamingFAERS: 1US FAERS
193Sedation complicationFAERS: 1US FAERS
194Seizure like phenomenaFAERS: 1US FAERS
195SepsisFAERS: 1US FAERS
196Sinus TachycardiaFAERS: 1US FAERS
197Skin WrinklingFAERS: 1US FAERS
198SnoringFAERS: 1US FAERS
199StaringFAERS: 1US FAERS
200Subcutaneous AbscessFAERS: 1US FAERS
201ThirstFAERS: 1US FAERS
202TrismusFAERS: 1US FAERS
203Troponin T increasedFAERS: 1US FAERS
204Ventricular arrhythmiaFAERS: 1US FAERS
205WheezingFAERS: 1US FAERS
206Wrong technique in drug usage processFAERS: 1US FAERS
207Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.